Logo image of ADNT

ADIENT PLC (ADNT) Stock Fundamental Analysis

NYSE:ADNT - New York Stock Exchange, Inc. - IE00BD845X29 - Common Stock - Currency: USD

12.23  +0.22 (+1.83%)

Fundamental Rating

4

Overall ADNT gets a fundamental rating of 4 out of 10. We evaluated ADNT against 81 industry peers in the Automobile Components industry. ADNT may be in some trouble as it scores bad on both profitability and health. ADNT is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

ADNT had positive earnings in the past year.
In the past year ADNT had a positive cash flow from operations.
In multiple years ADNT reported negative net income over the last 5 years.
ADNT had a positive operating cash flow in each of the past 5 years.
ADNT Yearly Net Income VS EBIT VS OCF VS FCFADNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B -1.5B

1.2 Ratios

ADNT has a worse Return On Assets (-0.02%) than 76.54% of its industry peers.
ADNT has a Return On Equity of -0.11%. This is in the lower half of the industry: ADNT underperforms 75.31% of its industry peers.
ADNT's Return On Invested Capital of 5.97% is on the low side compared to the rest of the industry. ADNT is outperformed by 69.14% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ADNT is below the industry average of 8.88%.
The 3 year average ROIC (5.11%) for ADNT is below the current ROIC(5.97%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.02%
ROE -0.11%
ROIC 5.97%
ROA(3y)0.35%
ROA(5y)1.2%
ROE(3y)1.42%
ROE(5y)1.16%
ROIC(3y)5.11%
ROIC(5y)4.23%
ADNT Yearly ROA, ROE, ROICADNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

1.3 Margins

In the last couple of years the Profit Margin of ADNT has declined.
With a Operating Margin value of 2.86%, ADNT is not doing good in the industry: 79.01% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of ADNT has grown nicely.
ADNT's Gross Margin of 6.18% is on the low side compared to the rest of the industry. ADNT is outperformed by 91.36% of its industry peers.
ADNT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.86%
PM (TTM) N/A
GM 6.18%
OM growth 3Y-7.97%
OM growth 5Y33.2%
PM growth 3Y-75.27%
PM growth 5YN/A
GM growth 3Y-5.89%
GM growth 5Y5.44%
ADNT Yearly Profit, Operating, Gross MarginsADNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ADNT is creating some value.
Compared to 1 year ago, ADNT has less shares outstanding
ADNT has less shares outstanding than it did 5 years ago.
ADNT has a better debt/assets ratio than last year.
ADNT Yearly Shares OutstandingADNT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ADNT Yearly Total Debt VS Total AssetsADNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

ADNT has an Altman-Z score of 1.85. This is not the best score and indicates that ADNT is in the grey zone with still only limited risk for bankruptcy at the moment.
ADNT has a worse Altman-Z score (1.85) than 79.01% of its industry peers.
The Debt to FCF ratio of ADNT is 7.15, which is on the high side as it means it would take ADNT, 7.15 years of fcf income to pay off all of its debts.
ADNT has a worse Debt to FCF ratio (7.15) than 69.14% of its industry peers.
ADNT has a Debt/Equity ratio of 1.28. This is a high value indicating a heavy dependency on external financing.
ADNT's Debt to Equity ratio of 1.28 is on the low side compared to the rest of the industry. ADNT is outperformed by 87.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF 7.15
Altman-Z 1.85
ROIC/WACC1.15
WACC5.2%
ADNT Yearly LT Debt VS Equity VS FCFADNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

2.3 Liquidity

ADNT has a Current Ratio of 1.08. This is a normal value and indicates that ADNT is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ADNT (1.08) is worse than 91.36% of its industry peers.
ADNT has a Quick Ratio of 1.08. This is a bad value and indicates that ADNT is not financially healthy enough and could expect problems in meeting its short term obligations.
ADNT has a worse Quick ratio (0.86) than 82.72% of its industry peers.
Industry RankSector Rank
Current Ratio 1.08
Quick Ratio 0.86
ADNT Yearly Current Assets VS Current LiabilitesADNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

4

3. Growth

3.1 Past

The earnings per share for ADNT have decreased strongly by -14.62% in the last year.
Measured over the past 5 years, ADNT shows a small growth in Earnings Per Share. The EPS has been growing by 2.56% on average per year.
The Revenue has decreased by -5.42% in the past year.
The Revenue has been decreasing by -2.33% on average over the past years.
EPS 1Y (TTM)-14.62%
EPS 3Y-3.98%
EPS 5Y2.56%
EPS Q2Q%-12.9%
Revenue 1Y (TTM)-5.42%
Revenue growth 3Y2.4%
Revenue growth 5Y-2.33%
Sales Q2Q%-4.51%

3.2 Future

The Earnings Per Share is expected to grow by 34.05% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 1.40% on average over the next years.
EPS Next Y-15.42%
EPS Next 2Y15.03%
EPS Next 3Y24.45%
EPS Next 5Y34.05%
Revenue Next Year-4.88%
Revenue Next 2Y-1.9%
Revenue Next 3Y-0.69%
Revenue Next 5Y1.4%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ADNT Yearly Revenue VS EstimatesADNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B 20B
ADNT Yearly EPS VS EstimatesADNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 2 4 6 8

8

4. Valuation

4.1 Price/Earnings Ratio

ADNT is valuated cheaply with a Price/Earnings ratio of 6.76.
81.48% of the companies in the same industry are more expensive than ADNT, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 28.33. ADNT is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 5.00, the valuation of ADNT can be described as very cheap.
Based on the Price/Forward Earnings ratio, ADNT is valued cheaply inside the industry as 88.89% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 21.37. ADNT is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 6.76
Fwd PE 5
ADNT Price Earnings VS Forward Price EarningsADNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ADNT is valued a bit cheaper than the industry average as 76.54% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, ADNT is valued cheaply inside the industry as 97.53% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 3.05
EV/EBITDA 3.43
ADNT Per share dataADNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

ADNT's earnings are expected to grow with 24.45% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)2.63
EPS Next 2Y15.03%
EPS Next 3Y24.45%

0

5. Dividend

5.1 Amount

ADNT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ADIENT PLC

NYSE:ADNT (4/23/2025, 3:55:01 PM)

12.23

+0.22 (+1.83%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)01-28 2025-01-28/bmo
Earnings (Next)05-07 2025-05-07/amc
Inst Owners102.52%
Inst Owner Change0.25%
Ins Owners0.86%
Ins Owner Change17.18%
Market Cap1.03B
Analysts51.25
Price Target20.78 (69.91%)
Short Float %6.58%
Short Ratio4.4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)33.62%
Min EPS beat(2)27.59%
Max EPS beat(2)39.64%
EPS beat(4)3
Avg EPS beat(4)10.71%
Min EPS beat(4)-49.75%
Max EPS beat(4)39.64%
EPS beat(8)4
Avg EPS beat(8)9.65%
EPS beat(12)6
Avg EPS beat(12)12.16%
EPS beat(16)8
Avg EPS beat(16)-9.78%
Revenue beat(2)1
Avg Revenue beat(2)0.76%
Min Revenue beat(2)-0.06%
Max Revenue beat(2)1.57%
Revenue beat(4)1
Avg Revenue beat(4)-1.55%
Min Revenue beat(4)-4.77%
Max Revenue beat(4)1.57%
Revenue beat(8)3
Avg Revenue beat(8)-0.98%
Revenue beat(12)4
Avg Revenue beat(12)-0.7%
Revenue beat(16)6
Avg Revenue beat(16)-0.83%
PT rev (1m)-3.55%
PT rev (3m)-15.5%
EPS NQ rev (1m)1.91%
EPS NQ rev (3m)-17.52%
EPS NY rev (1m)-11.44%
EPS NY rev (3m)-21.84%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.64%
Revenue NY rev (1m)-0.2%
Revenue NY rev (3m)-2.26%
Valuation
Industry RankSector Rank
PE 6.76
Fwd PE 5
P/S 0.07
P/FCF 3.05
P/OCF 1.68
P/B 0.55
P/tB N/A
EV/EBITDA 3.43
EPS(TTM)1.81
EY14.8%
EPS(NY)2.45
Fwd EY20.02%
FCF(TTM)4
FCFY32.73%
OCF(TTM)7.28
OCFY59.52%
SpS173.04
BVpS22.36
TBVpS-6.65
PEG (NY)N/A
PEG (5Y)2.63
Profitability
Industry RankSector Rank
ROA -0.02%
ROE -0.11%
ROCE 7.86%
ROIC 5.97%
ROICexc 7.13%
ROICexgc 15.86%
OM 2.86%
PM (TTM) N/A
GM 6.18%
FCFM 2.31%
ROA(3y)0.35%
ROA(5y)1.2%
ROE(3y)1.42%
ROE(5y)1.16%
ROIC(3y)5.11%
ROIC(5y)4.23%
ROICexc(3y)6.22%
ROICexc(5y)5.21%
ROICexgc(3y)13.54%
ROICexgc(5y)10.98%
ROCE(3y)6.73%
ROCE(5y)5.58%
ROICexcg growth 3Y4.55%
ROICexcg growth 5Y38.95%
ROICexc growth 3Y0.66%
ROICexc growth 5Y34.59%
OM growth 3Y-7.97%
OM growth 5Y33.2%
PM growth 3Y-75.27%
PM growth 5YN/A
GM growth 3Y-5.89%
GM growth 5Y5.44%
F-Score4
Asset Turnover1.7
Health
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF 7.15
Debt/EBITDA 3.22
Cap/Depr 83.59%
Cap/Sales 1.89%
Interest Coverage 250
Cash Conversion 82.12%
Profit Quality N/A
Current Ratio 1.08
Quick Ratio 0.86
Altman-Z 1.85
F-Score4
WACC5.2%
ROIC/WACC1.15
Cap/Depr(3y)73.03%
Cap/Depr(5y)79.22%
Cap/Sales(3y)1.69%
Cap/Sales(5y)1.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.62%
EPS 3Y-3.98%
EPS 5Y2.56%
EPS Q2Q%-12.9%
EPS Next Y-15.42%
EPS Next 2Y15.03%
EPS Next 3Y24.45%
EPS Next 5Y34.05%
Revenue 1Y (TTM)-5.42%
Revenue growth 3Y2.4%
Revenue growth 5Y-2.33%
Sales Q2Q%-4.51%
Revenue Next Year-4.88%
Revenue Next 2Y-1.9%
Revenue Next 3Y-0.69%
Revenue Next 5Y1.4%
EBIT growth 1Y-15.65%
EBIT growth 3Y-5.76%
EBIT growth 5Y30.09%
EBIT Next Year63.44%
EBIT Next 3Y23.35%
EBIT Next 5Y24.21%
FCF growth 1Y223.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y84.04%
OCF growth 3Y30.56%
OCF growth 5Y12.01%